Literature DB >> 35157807

Fsp27 plays a crucial role in muscle performance.

Mark Slayton1, Bijinu Balakrishnan1, Abhishek Gupta1, Scott Jobe2, Ishika Puri3, Savannah Neely4, Yoshikazu Tamori5, David W Russ6, Gozde Yildirim7, Shoshana Yakar7, Vishva M Sharma1, Vishwajeet Puri1.   

Abstract

Fsp27 was previously identified as a lipid droplet-associated protein in adipocytes. Various studies have shown that it plays a role in the regulation of lipid homeostasis in adipose tissue and liver. However, its function in muscle, which also accumulate and metabolize fat, remains completely unknown. Our present study identifies a novel role of Fsp27 in muscle performance. Here, we demonstrate that Fsp27-/- and Fsp27+/- mice, both males and females, had severely impaired muscle endurance and exercise capacity compared with wild-type controls. Liver and muscle glycogen stores were similar among all groups fed or fasted, and before or after exercise. Reduced muscle performance in Fsp27-/- and Fsp27+/- mice was associated with severely decreased fat content in the muscle. Furthermore, results in heterozygous Fsp27+/- mice indicate that Fsp27 haploinsufficiency undermines muscle performance in both males and females. In summary, our physiological findings reveal that Fsp27 plays a critical role in muscular fat storage, muscle endurance, and muscle strength.NEW & NOTEWORTHY This is the first study identifying Fsp27 as a novel protein associated with muscle metabolism. The Fsp27-knockout model shows that Fsp27 plays a role in muscular-fat storage, muscle endurance, and muscle strength, which ultimately impacts limb movement. In addition, our study suggests a potential metabolic paradox in which FSP27-knockout mice presumed to be metabolically healthy based on glucose utilization and oxidative metabolism are unhealthy in terms of exercise capacity and muscular performance.

Entities:  

Keywords:  Cidea; Cidec; diabetes; fat metabolism; lipid droplets; lipids; obesity

Mesh:

Substances:

Year:  2022        PMID: 35157807      PMCID: PMC8957325          DOI: 10.1152/ajpendo.00255.2021

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  25 in total

1.  Growth hormone controls lipolysis by regulation of FSP27 expression.

Authors:  Rita Sharma; Quyen Luong; Vishva M Sharma; Mitchell Harberson; Brian Harper; Andrew Colborn; Darlene E Berryman; Niels Jessen; Jens Otto Lunde Jørgensen; John J Kopchick; Vishwajeet Puri; Kevin Y Lee
Journal:  J Endocrinol       Date:  2018-12-01       Impact factor: 4.286

Review 2.  Exercise metabolism and the molecular regulation of skeletal muscle adaptation.

Authors:  Brendan Egan; Juleen R Zierath
Journal:  Cell Metab       Date:  2013-02-05       Impact factor: 27.287

Review 3.  Skeletal muscle energy metabolism during exercise.

Authors:  Mark Hargreaves; Lawrence L Spriet
Journal:  Nat Metab       Date:  2020-08-03

Review 4.  CIDE family proteins control lipid homeostasis and the development of metabolic diseases.

Authors:  Feng-Jung Chen; Yesheng Yin; Boon Tin Chua; Peng Li
Journal:  Traffic       Date:  2020-01       Impact factor: 6.215

5.  Growth hormone acts along the PPARγ-FSP27 axis to stimulate lipolysis in human adipocytes.

Authors:  Vishva M Sharma; Esben Thyssen Vestergaard; Niels Jessen; Peter Kolind-Thomsen; Birgitte Nellemann; Thomas S Nielsen; Mikkel Holm Vendelbo; Niels Møller; Rita Sharma; Kevin Y Lee; John J Kopchick; Jens Otto Lunde Jørgensen; Vishwajeet Puri
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-10-16       Impact factor: 4.310

6.  Fat-specific protein 27 inhibits lipolysis by facilitating the inhibitory effect of transcription factor Egr1 on transcription of adipose triglyceride lipase.

Authors:  Maneet Singh; Rajween Kaur; Mi-Jeong Lee; R Taylor Pickering; Vishva Mitra Sharma; Vishwajeet Puri; Konstantin V Kandror
Journal:  J Biol Chem       Date:  2014-04-17       Impact factor: 5.157

7.  Cidea is associated with lipid droplets and insulin sensitivity in humans.

Authors:  Vishwajeet Puri; Srijana Ranjit; Silvana Konda; Sarah M C Nicoloro; Juerg Straubhaar; Anil Chawla; My Chouinard; Chenyi Lin; Alison Burkart; Silvia Corvera; Richard A Perugini; Michael P Czech
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-28       Impact factor: 11.205

8.  FSP27 contributes to efficient energy storage in murine white adipocytes by promoting the formation of unilocular lipid droplets.

Authors:  Naonobu Nishino; Yoshikazu Tamori; Sanshiro Tateya; Takayuki Kawaguchi; Tetsuro Shibakusa; Wataru Mizunoya; Kazuo Inoue; Riko Kitazawa; Sohei Kitazawa; Yasushi Matsuki; Ryuji Hiramatsu; Satoru Masubuchi; Asako Omachi; Kazuhiro Kimura; Masayuki Saito; Taku Amo; Shigeo Ohta; Tomohiro Yamaguchi; Takashi Osumi; Jinglei Cheng; Toyoshi Fujimoto; Harumi Nakao; Kazuki Nakao; Atsu Aiba; Hitoshi Okamura; Tohru Fushiki; Masato Kasuga
Journal:  J Clin Invest       Date:  2008-08       Impact factor: 14.808

9.  Therapeutic silencing of fat-specific protein 27 improves glycemic control in mouse models of obesity and insulin resistance.

Authors:  Cédric Langhi; Noemí Arias; Ananthi Rajamoorthi; Jeannine Basta; Richard G Lee; Ángel Baldán
Journal:  J Lipid Res       Date:  2016-11-24       Impact factor: 5.922

10.  Partial lipodystrophy and insulin resistant diabetes in a patient with a homozygous nonsense mutation in CIDEC.

Authors:  Oscar Rubio-Cabezas; Vishwajeet Puri; Incoronata Murano; Vladimir Saudek; Robert K Semple; Satya Dash; Caroline S S Hyden; William Bottomley; Corinne Vigouroux; Jocelyne Magré; Philippa Raymond-Barker; Peter R Murgatroyd; Anil Chawla; Jeremy N Skepper; V Krishna Chatterjee; Sara Suliman; Ann-Marie Patch; Anil K Agarwal; Abhimanyu Garg; Inês Barroso; Saverio Cinti; Michael P Czech; Jesús Argente; Stephen O'Rahilly; David B Savage
Journal:  EMBO Mol Med       Date:  2009-08       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.